I use to think CoVid testing would come and go. Do you know how many people get the flu every year? Before CoVid did a doctor usually order lab work or did they just write a few scripts at the office.
Testing will be around for a long while, and if Biocept's press release with AEGEA (who granted them exclusivity on some switch blocker patents) which stated they have a test kit that is next generation and can differentiate strains then they will have a competitive advantage.
I don't know what the current revenues are, but if that poster was correct and they are doing 2000 tests a day ( I dont buy it) then the revenue is massive and a nice addition to oncology. Even 1000 tests a day is huge volume.
News 
Market Data 
Discover 
